Does low testosterone in older men contribute to muscle loss, low bone density, sexual dysfunction, and worse metabolic health?

In older men, declining testosterone levels are strongly associated with a cluster of physiological and metabolic changes, ranging from musculoskeletal decline to impaired glucose regulation.

Musculoskeletal and Bone Health

Low testosterone is a primary driver of sarcopenia (age-related muscle loss) and osteopenia (reduced bone density) through distinct hormonal pathways.

• Muscle Mass and Strength: Testosterone regulates muscle growth by binding to androgen receptors (AR) in skeletal muscle, which activates anabolic pathways (Akt/Notch) and inhibits myostatin, a negative regulator of muscle size. Research indicates that low levels increase pro-atrophic markers like Atrogin-1. Meta-analyses show that testosterone replacement therapy (TRT) in hypogonadal men over age 60 can increase lean body mass by approximately 2.54 kg and significantly improve handgrip strength.
• Bone Mineral Density (BMD): The hormone supports bone through direct action on osteoblasts and indirectly through aromatization into estradiol. Clinical trials in older men show that TRT can increase spine trabecular BMD by up to 7.5% over one year, compared to 2.4% in placebo groups. However, the risk of fractures is also influenced by sex hormone-binding globulin (SHBG) levels, which may be an even stronger predictor of fracture than testosterone alone.

Sexual and Metabolic Function

The association between low testosterone and sexual/metabolic health is well-documented, often involving bidirectional relationships with comorbid conditions.

• Sexual Dysfunction: There is a robust correlation between low serum testosterone and reductions in libido and erectile function. In the "Testosterone Trials" (TTrials) involving men aged 65+, normalizing testosterone levels significantly improved sexual desire and activity. While improvements in erectile function are noted, they are often more modest and may require adjunct therapies if vascular damage is present.
• Metabolic Markers: Men with low testosterone have a 1.69 to 2.32 times higher risk of metabolic syndrome. This relationship is bidirectional: visceral obesity and insulin resistance suppress testosterone production, while low testosterone further impairs insulin signaling and promotes fat storage. Clinical evidence demonstrates that restoring testosterone can reduce HbA1c by approximately 0.67% and improve waist circumference and HOMA-IR scores.

Bottom line

Low testosterone in older men is a validated clinical marker for reduced muscle mass, lower bone density, sexual dysfunction, and poor metabolic health. These associations are supported by both mechanistic pathways and clinical trials demonstrating that testosterone replacement can mitigate many of these age-related declines.